Partners & Investors

OUR CORE STRATEGY continues to revolve around business development.


New products are essential for growth and market leadership. Products must address therapeutic needs in safety, efficacy and improving quality of life.

With all of our stakeholders, we aim to develop relationships and improve networking with business partners and suppliers based on transparency and mutual trust. We believe our major strength is our approach to alliances and partnerships with licensees. We have clear and strong lines of communication which allow us to respond quickly and efficiently to customer and market requirements.

Business Development

Business Performance

Medexus continues to perform above expectations. With double digit growth expected in 2017, we are aggressively seeking new opportunities, in all therapeutic areas, to continue this in 2018.

Partners / Investor Opportunities

Medexus has set demanding goals for the future: Not only will we set out on an aggressive journey of growth and expansion; we will be the leading Canadian based supplier of innovative products for target markets.

We encourage and welcome new partners to join us. Please contact Medexus for information on partnership opportunities.

We are global in partners and continueto expand our reach:

Apotex
Medax
Giuliani
Takeda
FrezyDerm
Actelion
Bioclin
Bioiberica
Riemser